Skip to main content
. 2018 Nov 13;33(3):568–576. doi: 10.1111/jdv.15292

Table 1.

Patient disposition of the responder population during the Treatment Withdrawal Period and Retreatment Period in patients with plaque psoriasis (UNCOVER‐J)

n (%) Treatment withdrawal period (N = 70) Retreatment period (N = 67)
Completed period 67 (95.7) 60 (89.6)
Relapsed 61 (87.1) NA
Discontinued 3 (4.3) 7 (10.4)
Adverse event 1 (1.4) 3 (4.5)
Physician decision 2 (2.9) 1 (1.5)
Patient decision 0 2 (3.0)
Lack of efficacy 0 1 (1.5)

Of the 70 patients who entered the Treatment Withdrawal Period, three patients did not enter the following Retreatment Period (one patient who discontinued owing to an adverse event before Week 100 but did not relapse; one patient who discontinued owing to a physician decision before Week 100 and relapsed; one patient who relapsed before Week 100 but did not enter the Retreatment Period owing to a physician decision).

n, number in group; N, population size; NA, not applicable.